Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Zhou Aiping
Deubiquitination and Stabilization of Programmed Cell Death Ligand 1 by Ubiquitin-Specific Peptidase 9, X-Linked in Oral Squamous Cell Carcinoma
Cancer Medicine
Cancer Research
Nuclear Medicine
Radiology
Imaging
Oncology
Related publications
The Expression of Programmed Death Ligand-1 Within Stages of Oral Squamous Cell Carcinoma: Immunohistochemical Analysis
Journal of Advances in Medicine and Medical Research
Role of Ubiquitin-Specific Peptidase 22 in Carcinogenesis of Human Pharyngeal Squamous Cell Carcinoma
Molecular Medicine Reports
Oncology
Genetics
Molecular Biology
Biochemistry
Cancer Research
Molecular Medicine
Inflammation Promotes Oral Squamous Carcinoma Immune Evasion via Induced Programmed Death Ligand‑1 Surface Expression
Oncology Letters
Cancer Research
Oncology
Programmed Death-Ligand 1 Expression Correlates With Diminished CD8+ T Cell Infiltration and Predicts Poor Prognosis in Anal Squamous Cell Carcinoma Patients
Cancer Management and Research
Oncology
Ubiquitin-Specific Peptidase 9, X-Linked (USP9X) Modulates Activity of Mammalian Target of Rapamycin (mTOR)
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
Indoleamine 2,3-Dioxygenase 1 and Programmed Cell Death-Ligand 1 Co-Expression Predicts Poor Pathologic Response and Recurrence in Esophageal Squamous Cell Carcinoma After Neoadjuvant Chemoradiotherapy
Cancers
Cancer Research
Oncology
Programmed Death Ligand 1 in Non-Clear Cell Renal Cell Carcinoma and Correlation With Tumor Microenvironment and Prognostic Factors
Medical Journal of Islamic World Academy of Sciences
Concordance Among Four Commercially Available, Validated Programmed Cell Death Ligand-1 Assays in Urothelial Carcinoma
Diagnostic Pathology
Forensic Medicine
Medicine
Pathology
Histology
Clinical and Histologic Features of Lichenoid Mucocutaneous Eruptions Due to Anti–Programmed Cell Death 1 and Anti–Programmed Cell Death Ligand 1 Immunotherapy
JAMA Dermatology
Dermatology
Medicine